Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Jun;27(6):928–932. doi: 10.1128/aac.27.6.928

Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.

M G Bergeron, D Desaulniers, C Lessard, M Lemieux, J P Després, J Métras, G Raymond, G Brochu
PMCID: PMC180189  PMID: 4026265

Abstract

The concentrations of cefamandole, cloxacillin and fusicid acid were measured in the serum and heart tissue of 100 recipients of these drugs before cardiac surgery. During cardiopulmonary bypass, mean (+/- standard deviation) peak concentrations in serum of all patients were 63.0 +/- 34.0 micrograms of cefamandole per ml, 30.8 +/- 17.7 micrograms of cloxacillin per ml, and 32.4 +/- 10.8 micrograms of fusidic acid per ml. Mean (+/- standard deviation) concentrations in atrial appendages taken 1 h (+/- 15 min) after infusion were 21.3 +/- 11.0 micrograms of cefamandole per g, 23.8 +/- 17.3 micrograms of cloxacillin per g, and 10.7 +/- 4.2 micrograms of fusidic acid per g. No cloxacillin could be detected in 5 of 39 heart specimens. Mean tissue-to-serum ratios at 1 h for cefamandole, cloxacillin, and fusidic acid were respectively 0.35, 0.73, and 0.33. Fusidic acid, a drug which is highly effective in vitro against both methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis, was detectable in heart tissue in concentrations which were 12 times higher than the MICs of this agent against these resistant microorganisms.

Full text

PDF
928

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. L. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Antimicrob Agents Chemother. 1978 Sep;14(3):353–359. doi: 10.1128/aac.14.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Archer G. L., Polk R. E., Duma R. J., Lower R. Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valves. Antimicrob Agents Chemother. 1978 Jun;13(6):924–929. doi: 10.1128/aac.13.6.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Austin T. W., Coles J. C., Finley R., Schieven B. Prophylactic antibiotic therapy and heart valve replacement. Can J Surg. 1976 Jul;19(4):349–352. [PubMed] [Google Scholar]
  4. Bergeron M. G., Brusch J. L., Barza M., Weinstein L. Bactericidal activity and pharmacology of flucloxacillin. Am J Med Sci. 1976 Jan-Feb;271(1):13–20. doi: 10.1097/00000441-197601000-00002. [DOI] [PubMed] [Google Scholar]
  5. Bourgault A. M., Gauvreau L. Antimicrobial susceptibilities of coagulase-negative staphylococci isolated from urinary infections. Antimicrob Agents Chemother. 1983 May;23(5):793–795. doi: 10.1128/aac.23.5.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daschner F. D., Metz B., Spillner G., Buzello W., Schlosser V. Concentrations of cefamandole and cefsulodin in serum, heart valves, subcutaneous tissue, and muscle of patients undergoing open-heart surgery. J Infect Dis. 1980 Aug;142(2):290–290. doi: 10.1093/infdis/142.2.290. [DOI] [PubMed] [Google Scholar]
  7. Eykyn S., Jenkins C., King A., Phillips I. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother. 1973 Jun;3(6):657–661. doi: 10.1128/aac.3.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GODTFREDSEN W., ROHOLT K., TYBRING L. Fucidin: a new orally active antibiotic. Lancet. 1962 May 5;1(7236):928–931. doi: 10.1016/s0140-6736(62)91968-2. [DOI] [PubMed] [Google Scholar]
  9. Ghoneim A. T., Tandon A. P., Ionescu M. I. Comparative study of cefamandole versus ampicillin plus cloxacillin: prophylactic antibiotics in cardiac surgery. Ann Thorac Surg. 1982 Feb;33(2):152–158. doi: 10.1016/s0003-4975(10)61902-9. [DOI] [PubMed] [Google Scholar]
  10. Hierholzer G., Rehn J., Knothe H., Masterson J. Antibiotic therapy of chronic post-traumatic osteomyelitis. J Bone Joint Surg Br. 1974 Nov;56-B(4):721–729. doi: 10.1302/0301-620X.56B4.721. [DOI] [PubMed] [Google Scholar]
  11. Karchmer A. W., Archer G. L., Dismukes W. E. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med. 1983 Apr;98(4):447–455. doi: 10.7326/0003-4819-98-4-447. [DOI] [PubMed] [Google Scholar]
  12. Kiss I. J., Faragó E., Gömöry A., Szamaránszky J. Investigations on the flucloxacillin levels in human serum, lung tissue, pericardial fluid and heart tissue. Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):405–411. [PubMed] [Google Scholar]
  13. Markowitz N., Pohlod D. J., Saravolatz L. D., Quinn E. L. In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agents Chemother. 1983 Mar;23(3):450–457. doi: 10.1128/aac.23.3.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Masur H., Johnson W. D., Jr Prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1980 Jul;80(1):31–37. [PubMed] [Google Scholar]
  15. Olson N. H., Nightingale C. H., Quintiliani R. Penetration characteristics of cefamandole into the right atrial appendage and pericardial fluid in patients undergoing open-heart surgery. Ann Thorac Surg. 1980 Feb;29(2):104–108. doi: 10.1016/s0003-4975(10)61644-x. [DOI] [PubMed] [Google Scholar]
  16. Polk R. E., Archer G. L., Lower R. Cefamandole kinetics during cardiopulmonary bypass. Clin Pharmacol Ther. 1978 Apr;23(4):473–480. doi: 10.1002/cpt1978234473. [DOI] [PubMed] [Google Scholar]
  17. Price S. B., Flournoy D. J. Comparison of antimicrobial susceptibility patterns among coagulase-negative staphylococci. Antimicrob Agents Chemother. 1982 Mar;21(3):436–440. doi: 10.1128/aac.21.3.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pulverer G., Damen G., Neugebauer M. Antibiotic resistance of Staphylococcus albus. Med Microbiol Immunol. 1972;158(1):32–43. doi: 10.1007/BF02122006. [DOI] [PubMed] [Google Scholar]
  19. Raeburn J. A. A method for studying antibiotic concentrations in inflammatory exudate. J Clin Pathol. 1971 Oct;24(7):633–635. doi: 10.1136/jcp.24.7.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wise R., Pippard M., Mitchard M. The disposition of sodium fusidate in man. Br J Clin Pharmacol. 1977 Oct;4(5):615–619. doi: 10.1111/j.1365-2125.1977.tb00795.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES